VRTX

Vertex Pharma (VRTX) shares are flagging nicely near recent highs and have stayed wildly strong relative to the broad market. VRTX can break out above...

Vertex Pharma (VRTX) shares closed on highs Monday back above the 8 and 21 EMA’s as it tries to take out a small trendline from...

Vertex Pharma (VRTX) – VRTX is a $68.66B global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases....

Abbott Labs (ABT) earnings call on Libre growth and drivers… “It continues to grow at a very strong rate and a very large base. 35...

Vertex (VRTX) at JPM Healthcare Conference on CF program and Phase 3 milestones… “And in 2021, we also achieved important risk-lowering milestones in progress in...

Trade Date Ticker Insider Name Title Price Qty Value 9/8/2021 ASAN Moskovitz Dustin A. Pres, CEO, Chair, 10% $96.49 750,000 $72,367,611 7/28/2021 SUI Shiffman Gary A COB,...

Vertex (VRTX) sizable insider buy this week from director Bruce Sachs of 15,000 shares at $197.91, a more than $2.965M purchase. This is the largest –...

Translate Bio (TBIO) screened among the more intriguing small cap Biotech stocks into 2021 and shares at +17% YTD versus the XBI at -4.6% have...